Paul Saladino

one group has more than double the amount of cholesterol the other group has you know but they have the same amount of plaque and the group on the keto group actually was trending toward less fat, less fat in the arteries, less atherosclerosis. And so people might say, but they still had atherosclerosis. Well, yeah, you don't know what they did before, right?

So what's being said here is that these people had been on a ketogenic diet for an average of three years. They'd probably had elevated cholesterol, LDL cholesterol for three to five years, which most people cardiologists most in the lipid space would agree is enough time to see accelerated atherosclerosis when you have more of that cholesterol in your body.

So what's being said here is that these people had been on a ketogenic diet for an average of three years. They'd probably had elevated cholesterol, LDL cholesterol for three to five years, which most people cardiologists most in the lipid space would agree is enough time to see accelerated atherosclerosis when you have more of that cholesterol in your body.

So what's being said here is that these people had been on a ketogenic diet for an average of three years. They'd probably had elevated cholesterol, LDL cholesterol for three to five years, which most people cardiologists most in the lipid space would agree is enough time to see accelerated atherosclerosis when you have more of that cholesterol in your body.

And if LDL cholesterol is causing atherosclerosis, you should see more atheromas. You should see more atherosclerosis in that population, but you don't. Again, we don't know what they did before. It's not that people on ketogenic diets in the study had zero. but we don't have any idea what they were doing before. They could have had it previously. They had less.

And if LDL cholesterol is causing atherosclerosis, you should see more atheromas. You should see more atherosclerosis in that population, but you don't. Again, we don't know what they did before. It's not that people on ketogenic diets in the study had zero. but we don't have any idea what they were doing before. They could have had it previously. They had less.

And if LDL cholesterol is causing atherosclerosis, you should see more atheromas. You should see more atherosclerosis in that population, but you don't. Again, we don't know what they did before. It's not that people on ketogenic diets in the study had zero. but we don't have any idea what they were doing before. They could have had it previously. They had less.

They had less than the Miami Heart Group, which has a much lower LDL. That raises some pretty major questions. And when you look at the analysis, there was no correlation between serum cholesterol, LDL-C, not LDL, Yeah, the LDL-C. There was no correlation between LDL-C and the plaque burden in those people. Zero. Oh, shit. So if LDL is causal, how is that possible?

They had less than the Miami Heart Group, which has a much lower LDL. That raises some pretty major questions. And when you look at the analysis, there was no correlation between serum cholesterol, LDL-C, not LDL, Yeah, the LDL-C. There was no correlation between LDL-C and the plaque burden in those people. Zero. Oh, shit. So if LDL is causal, how is that possible?

They had less than the Miami Heart Group, which has a much lower LDL. That raises some pretty major questions. And when you look at the analysis, there was no correlation between serum cholesterol, LDL-C, not LDL, Yeah, the LDL-C. There was no correlation between LDL-C and the plaque burden in those people. Zero. Oh, shit. So if LDL is causal, how is that possible?

So we just see the whole thing starts to get really complicated and confusing, but I'll just... The framework, the context is important. It's all about insulin resistance, in my opinion. My strong belief, I should say. It's all about metabolic health. If you're metabolically healthy, you... LDL is not a problem. And you really have to be metabolically healthy.

So we just see the whole thing starts to get really complicated and confusing, but I'll just... The framework, the context is important. It's all about insulin resistance, in my opinion. My strong belief, I should say. It's all about metabolic health. If you're metabolically healthy, you... LDL is not a problem. And you really have to be metabolically healthy.

So we just see the whole thing starts to get really complicated and confusing, but I'll just... The framework, the context is important. It's all about insulin resistance, in my opinion. My strong belief, I should say. It's all about metabolic health. If you're metabolically healthy, you... LDL is not a problem. And you really have to be metabolically healthy.

And whether you're keto, which I'm not a huge fan of long-term for most people, or you're not keto, being metabolically healthy is what we should be focusing on. We are hyper-focused in Western medicine on LDL cholesterol because the statin industry is a multi-billion, potentially more than that, industry.

And whether you're keto, which I'm not a huge fan of long-term for most people, or you're not keto, being metabolically healthy is what we should be focusing on. We are hyper-focused in Western medicine on LDL cholesterol because the statin industry is a multi-billion, potentially more than that, industry.

And whether you're keto, which I'm not a huge fan of long-term for most people, or you're not keto, being metabolically healthy is what we should be focusing on. We are hyper-focused in Western medicine on LDL cholesterol because the statin industry is a multi-billion, potentially more than that, industry.

So if LDL doesn't cause atherosclerosis, there's still a place for statins in the drug supply, but maybe we wouldn't be giving them out as much as we are now. And the whole paradigm starts to shift. We need to fix insulin resistance. And that is something that again, 86 to 93% of Americans have some degree of. That's the problem. But we think we're doing a good job as doctors.

So if LDL doesn't cause atherosclerosis, there's still a place for statins in the drug supply, but maybe we wouldn't be giving them out as much as we are now. And the whole paradigm starts to shift. We need to fix insulin resistance. And that is something that again, 86 to 93% of Americans have some degree of. That's the problem. But we think we're doing a good job as doctors.

So if LDL doesn't cause atherosclerosis, there's still a place for statins in the drug supply, but maybe we wouldn't be giving them out as much as we are now. And the whole paradigm starts to shift. We need to fix insulin resistance. And that is something that again, 86 to 93% of Americans have some degree of. That's the problem. But we think we're doing a good job as doctors.

Remember, I did four years of cardiology as a PA. I gave a lot of statin prescriptions and I was proud of it at the time because I didn't know any better. So I've been in this world. We're treating the wrong thing and we're worried about the wrong things.